AcuityMD in the news

August 14, 2026

AI is changing MedTech sales—and the biggest opportunity isn't automation.

August 4, 2026

AI is increasingly moving beyond routine productivity tasks to influence how MedTech sales teams prioritize opportunities and allocate their time.

July 23, 2026

An AcuityMD-sponsored survey of 150 MedTech reps finds AI users 3x likelier to hit quota — but only 36% use AI, and 11% for strategic work. Compliance, training gaps and generic tools stall adoption. The device-maker question, sources argue, is now how to deploy AI, not whether.

May 13, 2026

Artificial intelligence has entered the world of sales calls, and it is changing the conversations between providers and MedTech companies seeking to close a deal.

April 22, 2026

AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to use its artificial intelligence (AI) platform to boost multiple aspects of how MedTech companies operate.

April 21, 2026

MedTech software platform AcuityMD raised $80 million in Series C funding at a $955 million valuation, CEO Michael Monovoukas tells Axios Pro exclusively.

April 2, 2026

Through the illustration of a real-world case, this article shares how a company was able to penetrate the VA healthcare system with a data management solution.

February 12, 2026

AcuityMD CRO Alex Wakefield shares what MedTech companies have to do to optimize and maximize the effectiveness of their sales rep teams in the new year and going forward.

January 3, 2023

The top trend that could define MedTech in 2023? Empower your salesforce (or lose your people), according to MD+DI. "The smart companies are going to be the ones that wake up to that earlier and start investing in empowering their salesforce as opposed to monitoring or taking a Big Brother approach," says AcuityMD CEO Michael Monovoukas.

November 19, 2025

AcuityMD experts predict AI will redefine the MedTech value demonstration in 2026, with commercial teams being forced to adapt faster than ever.

March 6, 2025

Between 2021 and 2024, the share of spine surgeries performed in the ASC setting has grown by 8% year over year, according to data from MedTech intelligence platform AcuityMD.

November 15, 2022

To accelerate patient access to its non-pharmaceutical therapy for opioid use disorder, Spark Biomedical has teamed up with AcuityMD on the launch of a wearable neurostimulation device.

December 15, 2025

Alex Wakefield, Chief Revenue Officer at AcuityMD, joins other healthcare and MedTech leaders to offer their 2026 predictions for the industry.

October 21, 2025

In recognition of Children’s Health Month, AcuityMD, the AI platform for MedTech, announced that Preceptis Medical has selected its platform to support an expanded market launch of the Hummingbird® Tympanostomy Tube System (TTS).

August 12, 2025

We’re honored to be recognized by Forbes among the world’s most promising companies shaping the future. This recognition is more than just a milestone; it’s a reflection of our team’s relentless commitment to accelerating the adoption of cutting-edge medical technologies.

March 13, 2025

AcuityMD, a commercial intelligence platform for the MedTech industry, unveiled new data at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting related to the shift of higher-acuity procedures into outpatient settings. AcuityMD used U.S. Centers for Medicare & Medicaid Services (CMS) data and over 300 million patient claims to conduct its research.

May 16, 2023

Digital Crusaders are those who advance digital platforms to transform marketing and company operations. With AcuityMD, Mike identified a clear industry need and is helping MedTech companies bring innovations to market that positively impact patients’ lives.

August 4, 2025

The MedTech M&A landscape is experiencing a resurgence fueled by significant capital from private equity and venture firms, says Alex Wakefield, CRO of AcuityMD. Building strong relationships with physicians remains crucial in MedTech, and defining an exit strategy early is imperative.

October 5, 2024

A recent survey reveals that 100% of MedTech executives believe poor contract management significantly impacts revenue. Effective contract management is crucial for boosting profit margins in the stagnating MedTech industry

September 4, 2025

After a few mixed years in medical technology mergers and acquisition activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A transactions totaling $9.2 billion, compared to 62 deals worth $2.7 billion in Q1 2024, according to J.P. Morgan’s MedTech sector report.

December 18, 2025

Mike Monovoukas, CEO and co-founder of AcuityMD, and Alex Wakefield, Chief Revenue Officer of AcuityMD, share their predictions for the MedTech industry in 2026.

January 5, 2026

Alex Wakefield, AcuityMD Chief Revenue Officer, predicts that in 2026 MedTech commercial teams will favor weekly sprints like tech companies use over static annual plans.

July 29, 2025

Medical device companies are changing healthcare delivery by using advanced commercial intelligence platforms that track complete patient journeys across providers, diagnoses, and treatments, solving the persistent challenge of murky referral networks.

November 19, 2025

Lumos Diagnostics has signed a strategic collaboration with AcuityMD to sharpen visibility around real-world reimbursement patterns. The partnership is designed to help Lumos navigate one of the most critical — and most challenging — levers in US diagnostic adoption: establishing dependable, repeatable reimbursement across private and public payers.

January 7, 2026

The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.

January 27, 2026

2026 will be the year that artificial intelligence accelerates multiple aspects of the medical technology discovery and development pipeline, industry leaders predict.

March 11, 2025

The MedTech sector faces growing commercialization challenges, but leveraging precise market intelligence can help companies, particularly startups, optimize strategies, and improve product adoption.

February 3, 2026

Dave Carey, CEO, Preceptis Medical and Michael Monovoukas, CEO, co-founder, AcuityMD note the importance of shifting ear tube procedures into the office, reducing anesthesia risk, and how AI-driven data and adaptive commercial strategies are becoming critical to scaling new MedTech innovations.

July 4, 2023

Successfully introducing a product into the MedTech market can be challenging. Now, experts are carving out a clearer pathway.

April 5, 2023

AcuityMD’s platform enables Dilon to quickly identify physicians to treat surgical breast cancer patients.

November 21, 2022

Officials at Spark Biomedical and AcuityMD think their partnership could accelerate the commercialization of Spark’s potentially game-changing platform.

March 15, 2024

AcuityMD co-founder and CEO Mike Monovoukas details how MedTech innovators are missing out on substantial revenue opportunities while incurring administrative costs from disjointed contract management.

December 19, 2023

CEO and co-founder Mike Monovoukas sits down with MedAd News and PharmaLive to discuss the top trends in store for 2024.

January 11, 2023

Are dated software systems holding MedTech back? AcuityMD CEO Michael Monovoukas shares what medical technology companies can achieve when they have the right tools -- and the risks if they don't.

August 9, 2023

While MedTech commercialization is complex and different for each product, having a platform that efficiently and accurately identifies new opportunities is invaluable. In this article, Anika Therapeutics shares how new data insights enabled their sales reps to drive more effective call plans -- surfacing over 500 relevant surgeons and more than $20 million in pipeline opportunities.

November 28, 2023

Understanding how to analyze and leverage data for medical device marketing is critical to product launch success. In this Life Sciences Intelligence article, learn why it’s critical for MedTech companies to understand their ICP (Ideal Customer Profile) even beyond product launch, and predictions for what 2024 will bring to the MedTech space.

March 25, 2025

Newsweek and data research firm Plant-A Insights Group are proud to present America's Greatest Startup Workplaces 2025. This list spotlights 250 exceptional companies across the U.S. that have created dynamic, supportive and rewarding environments for their employees.

May 25, 2021

“There are thousands of products being launched each year and so it’s almost impossible for a surgeon, after they’ve graduated fellowship or residency to keep track of the latest and greatest medical technology out there,” Monovoukas said. “We view this as a software and coordination problem, where you have all this data out there and it’s inefficient in getting to the decision-maker.”

August 13, 2024

AcuityMD announced $45 million in new funding to expand its commercial intelligence platform and advance the company's mission of accelerating adoption of cutting-edge MedTech.

December 13, 2022

"A lot of folks have taken almost a pejorative framing, describing the medical technology industry as behind pharma or behind other industries,” Monovoukas told Med Ad News. "The reality is the medical device industry has never had a tool that was built with their own needs and use cases in mind."

December 31, 2025

Mike Monovoukas, CEO and co-founder, and Alex Wakefield, Chief Revenue Officer at AcuityMD share their predictions on how AI will change how MedTech commercial teams operate and prove clinical and financial value in 2026.

March 15, 2025

Share of spinal surgeries performed in an outpatient setting increasing 8% year over year – improving patient experience, reducing financial burden, creating opportunities for device companies.

March 13, 2025

A new study by AcuityMD, presented at AAOS 2025, highlights the continued shift of spinal surgeries to the outpatient setting, with state-by-state variability in ASC adoption. While hospitals still dominate spinal procedures, advancements in minimally invasive techniques and medical technologies are major drivers of spinal surgeries in the ASC setting.

October 8, 2025

AcuityMD, the AI platform for MedTech, announced today at its annual Flywheel event for commercial leaders a major expansion of its platform with new AI tools to give medical device companies visibility into forecasted sales performance, business risks, and next-best actions to reach their goals.

October 10, 2023

Boston Business Journal profiles co-founder and CEO Mike Monovoukas in their 40 Under 40 feature, recognizing Boston's best and brightest young professionals.